Tag: Europe
-
Microbiome Drug Candidate Licensed in $525M Deal
A therapy designed to regenerate healthy gut microbes for treating dangerous intestinal infections is licensed for commercialization to Nestlé Health Science.
-
Biotechs Partner on Crispr Therapies for Neuro Disorders
Two biotechnology companies are designing therapies to deliver edited genes to treat Friedreich’s ataxia and amyotrophic lateral sclerosis, or ALS.
-
Plant-Based Lipids Developed for mRNA Vaccines
Chemists at industry and academic labs created safer lipids for delivering messenger RNA vaccines, such as those protecting against Covid-19.
-
Biotechs Partner on Gene-Edited Cancer Cell Therapies
Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immune-system cells to treat cancer.
-
Moderna Supplying 500M Vaccine Doses to Covax
Moderna Inc. is providing up to 500 million doses of its Covid-19 vaccine to the Covax Facility, an international project distributing vaccines to low-income countries.
-
Vaccine Stops Lyme Bacteria in Preclinical Test
A study with lab mice shows an experimental vaccine with engineered bacteria produces antibodies and protects against microbes causing Lyme disease.
-
NIH Trial Testing mRNA Vaccine Allergic Effects
A clinical trial is underway testing for allergic reactions to Covid-19 vaccines using messenger RNA for invoking an immune response.
-
Trial Shows Inhaled Covid-19 Therapy Safe
Results of a clinical trial show an anti-microbial treatment for Covid-19 infections given as a nasal spray is safe and well-tolerated in healthy volunteers.
-
Cell-Based Fish Company Gains $8.25M in Seed Funds
The start-up enterprise Bluu Biosciences is underway creating seafood products from fish stem cells, and raising $US 8.25 million in seed funds.
-
Precision Cancer Immunotherapy Biotech Underway
A new company is beginning work on a safer form of cancer immunotherapy that avoids toxic off-target effects, and raising $55 million in venture funds.